Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising outcomes. However, the expense of this innovative drug and its access have become key concerns for patients and healthcare professionals. While tirzepatide has been cleared by regulatory agencies, its costly nature presents a significant challenge to man